Latest Personalized medicine Stories
SAN DIEGO, Sept. 16, 2014 /PRNewswire/ -- Denovo Biopharma, LLC, today announced that it has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Company (NYSE: LLY).
Results Suggest that Oncotype DX® Colon Cancer Test May Reduce Medical Costs Associated with Stage II Disease While Increasing Patient Well-being REDWOOD CITY, Calif., Sept.
Selected to Showcase Healthcare Innovation at TEDMED WASHINGTON, Sept.
- Findings and research approach published in Nature Communications - CAMBRIDGE, Mass., Sept.
ReportsnReports.com adds "Companion Diagnostics Market by Technology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical
NEW YORK, Sept.
First two courses in program launch on September 1, 2014. STANFORD, Calif., Sept.
Transparency Market Research has published a new report titled "Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report